drugset

drugset / Trial / NCT04345419

Remdesivir Efficacy in Coronavirus Disease

NCT04345419 ↗

Phase 2/3 Completed 200 enrolled Tanta University

RandomizedParallel-groupSingle-blindTreatment

Summary

COVID 19 treatment using Remedesvir.

Timeline

Start: 2020-06-16
Primary completion: 2020-12-01
Completion: 2020-12-01

Publications

Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf MI, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Remdesivir	Small molecule	—	—

Indications